Safety, Pharmacokinetics, and Dose Recommendations for Nirmatrelvir/Ritonavir in Individuals with Mild to Moderate COVID-19 and Severe Renal Impairment.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/41823072

Candace R Bramson; Haihong Shi; Jacqueline Gerhart; Jennifer Hammond; Michelle Goulding; Olayide Oladoyinbo; Phylinda L S Chan; Sunring Chime

Mar 13, 2026